Exploring the Fetal Origins Hypothesis in Diverse Youth
Project Number5R01DK068001-03
Contact PI/Project LeaderDABELEA, DANA
Awardee OrganizationUNIVERSITY OF COLORADO DENVER
Description
Abstract Text
DESCRIPTION (provided by applicant): Fetal life is considered one of the critical (or sensitive) periods when an exposure may have lifelong effects. Increased adiposity in later life seems to occur at both ends of the birth weigh spectrum: generalized obesity with higher birth weight and increased visceral adiposity and its metabolic consequences at lower birth weights. Whether or not these phenotypes are detectable in exposed children and whether or not they have common biologic pathways is a focus of this proposal. The specific aims of this proposal are: Aim No. 1: To examine in parallel the long-term consequences of intrauterine exposure to excess nutrition (maternal diabetes) and under nutrition (growth restriction) on/childhood body size, fat patterning and markers of insulin resistance, among children of different ethnic groups. Aim No. 2. To explore hypothesis of intrauterine hormonal "programming" through which fetal exposures could increase the risk of obesity and insulin resistance in children.
The proposed project is a prospective study proposing to enroll a total of 810 eight to eleven-year old offspring of diabetic pregnancies (exposed group-1), offspring of non-diabetic pregnancies with intrauterine growth restraint (exposed group-2), and control children (unexposed group), as well as their biological mothers, in three ethnic groups (non-Hispanic whites, Hispanics, and African-Americans). Comparison of exposed and unexposed groups will allow assessment and disentangling of the effects of exposure to diabetes mellitus in utero and intrauterine growth restraint on body size, fat patterning and insulin resistance markers and features later in childhood. The proposed research should also help understand whether these exposures have direct biological influences or are mediated through lifestyle choices. Such studies could ultimately lead to the development of strategies for early life prevention of future chronic disorders.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
041096314
UEI
MW8JHK6ZYEX8
Project Start Date
14-September-2005
Project End Date
30-June-2010
Budget Start Date
01-July-2007
Budget End Date
30-June-2008
Project Funding Information for 2007
Total Funding
$520,925
Direct Costs
$352,482
Indirect Costs
$168,443
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Diabetes and Digestive and Kidney Diseases
$520,925
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK068001-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK068001-03
Patents
No Patents information available for 5R01DK068001-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK068001-03
Clinical Studies
No Clinical Studies information available for 5R01DK068001-03
News and More
Related News Releases
No news release information available for 5R01DK068001-03
History
No Historical information available for 5R01DK068001-03
Similar Projects
No Similar Projects information available for 5R01DK068001-03